Direct link to this page: http://www.hta.ac.uk/1381

Details of HTA journal title

Last updated: 12 November 2008 - Next update due: 18 November 2008

Research type:

NICE Technology Assessment Report (TAR) 

Title (lead author) etc:

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis  (Stevenson) 160 pages, Volume 9, number 22

Link to NICE guidance page

DOI

10.3310/hta9220
|  View/print executive summary
|  View/print abstract
|  View full text in pdf format (1437 KB)
| View separate 168 page appendix in pdf format (663 KB)
The appendix is only available electronically. It is not available in the printed version.
| Buy a printed version of this title - cost £20.00 each. [How to order]
# This title is available on our CD-ROM of the journal.
| Order a CD-ROM - free of charge worldwide.
#  Go to our correspondence page to comment on this publication  
Outputs in journals arising from this project

Special notes  

Erratum pages have been issued for this title.Download/view the erratum pages.  

Project ref:

01/58/01 

Original project title:

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis 

Chief Investigator:

School of Health and Related Research (ScHARR-TAG), University of Sheffield  

Start Date:

September 2002.  

Publication date:

June 2005

Cost:

 This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis

MeSH* index primary terms:

OSTEOPOROSIS Q-prevention-&-control; OSTEOPOROSIS Q-economics (* = Medical Subject Headings)

MeSH* index secondary terms:

HUMAN; FEMALE; SELECTIVE-ESTROGEN-RECEPTOR-MODULATORS Q-therapeutic-use; PARATHYROID-HORMONE Q-therapeutic-use; POSTMENOPAUSE  (* = Medical Subject Headings)

NRR* number, if applicable:

N0484131806 (*National Research Register) 

Project Protocol:

Project protocol not available

Printed copies of this title despatched:

115 (Figures relate to the previous calendar month)

Downloads/Views of electronic version from website:

83626 (Figures are cumulative.) Last updated 15th October 2008.

URL of this page:

http://www.hta.ac.uk/1381

Outputs from this project

  • Stevenson, M.; Oakley, J.; Chilcott, J.. Gaussian process modelling in conjunction with individual patient simulation modelling. A case study describing the calculation of cost-effectiveness ratios for the treatment of osteoporosis. Medical Decision Making: 21:1: 89:100.
  • Stevenson, MD; Brazier, JE; Calvert, NW; Lloyd-Jones, M; Oakley, JE; Kanis, JA. Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women. Journal of the Operational Research Society vol56 pages 214-221.
Wed, 12 Nov 2008 14:55:48 +0000

Advanced search How to use the search function